Iotrolan: uses, dosing, side effects & brands
Iotrolan is a medicine sold in the U.S. under 2 brand and generic names. Below: what the FDA label says, every product that contains it, what the pills look like, and its recall record.
Key facts
- Available as
- Injectable
- Sold as
- 2 products — Osmovist 190 and Osmovist 240
- Prescription?
- Prescription only
- Generic available?
- Not in our catalog
Every iotrolan product we track (2)
Same active ingredient — different manufacturer, form, price and FDA recall record. That last one is what our independent score measures.
| # | Drug | Rating | Type | Form | Generic? | Pharmacy pays | |
|---|---|---|---|---|---|---|---|
| 1 | Not yet rated | Prescription | Injectable | No data | — | View → | |
| 2 | Not yet rated | Prescription | Injectable | No data | — | View → |
What people report to the FDA about iotrolan
The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 7 reports naming iotrolan, and the FDA flagged 86% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:
- posterior reversible encephalopathy syndrome3 reports
- anterior spinal artery syndrome1 reports
- blindness cortical1 reports
- blindness transient1 reports
- brain oedema1 reports
- central nervous system lesion1 reports
- cerebral hyperperfusion syndrome1 reports
- deep vein thrombosis1 reports
Read these as a signal, not a rate. A report does not mean iotrolan caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label section above.
Source: openFDA drug/event (FAERS), retrieved July 25, 2026.
Related calculators
Frequently asked questions
Can you take iotrolan with other medicines?
It depends on the medicine. We check it against the FDA labels rather than guessing: our interaction checker searches each drug's own label for the other and quotes what it says, naming the section it came from. Run iotrolan against whatever else you take — and remember that a label not naming a drug is not the same as that combination being safe.
What brand names is iotrolan sold under?
We track 2 iotrolan-containing products in the U.S.: Osmovist 190 and Osmovist 240. They are the same active ingredient; they differ in form, manufacturer, price and FDA recall record.
What forms does iotrolan come in?
Across the brands we track, iotrolan is currently marketed as injectable, per the FDA's National Drug Code Directory. Each form is dosed differently — follow the label for the exact product you were prescribed.
Is there a generic iotrolan?
We do not currently list a generic-labelled iotrolan product. That does not always mean none exists — it means none appears under a generic name in the FDA data we track. Ask your pharmacist.
Cite this page
- APA
- pharmaranks. (2026, July 24). Iotrolan: uses, dosing, side effects & brands. https://pharmaranks.com/drugs/iotrolan
- MLA
- “Iotrolan: uses, dosing, side effects & brands.” pharmaranks, 24 July 2026, https://pharmaranks.com/drugs/iotrolan.
We summarise public FDA and NIH sources — for a clinical claim, cite the primary source we link to as well.
Sources: FDA openFDA drug label, National Drug Code Directory, and Enforcement (recall) database. This page reproduces public FDA data and is not medical advice. Dosing is set by your prescriber.
Read the full FDA label for iotrolan on DailyMed (NIH) ↗.